These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 8931343

  • 1. Effects of captopril on renal functions, renal and portal hemodynamics in patients with cirrhosis.
    Tsai YT, Lin HC, Lee FY, Hou MC, Wang SS, Lee SD.
    Proc Natl Sci Counc Repub China B; 1996 Apr; 20(2):44-50. PubMed ID: 8931343
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Acute effects of captopril on systemic and renal hemodynamics and on renal function in cirrhotic patients with ascites.
    Pariente EA, Bataille C, Bercoff E, Lebrec D.
    Gastroenterology; 1985 May; 88(5 Pt 1):1255-9. PubMed ID: 3884428
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G, Lazzeri C, Pascale A, Sestini S, Bisi G, Sciagrà R, Vecchiarino S, Raggi VC, Barletta G, Laffi G, Gentilini P.
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [Abstract] [Full Text] [Related]

  • 8. Effects of converting-enzyme inhibition on cardiorenal hemodynamics in patients with chronic congestive heart failure.
    Kubo S, Nishioka A, Nishimura H, Kawamura K, Takatsu T.
    J Cardiovasc Pharmacol; 1985 May; 7(4):753-9. PubMed ID: 2410718
    [Abstract] [Full Text] [Related]

  • 9. Portal and systemic hemodynamics and humoral factors in cirrhosis with and without ascites.
    Hayes PC, Cumming AD, Craig KJ, Watson M, Bouchier IA.
    Am J Gastroenterol; 1992 Oct; 87(10):1433-8. PubMed ID: 1415100
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure.
    Rademaker MT, Charles CJ, Nicholls MG, Richards AM.
    Clin Sci (Lond); 2008 May; 114(10):635-42. PubMed ID: 18052934
    [Abstract] [Full Text] [Related]

  • 15. Interrelationships between systemic hemodynamics, urinary sodium excretion, and renin-angiotensin system in cirrhosis.
    Aliaga L, Zozoya JM, Omar M, Mediavilla JD, Prieto J.
    Acta Gastroenterol Belg; 1995 May; 58(2):213-21. PubMed ID: 7571982
    [Abstract] [Full Text] [Related]

  • 16. The role of renal hemodynamics in the antihypertensive effect of captopril.
    Ando K, Fujita T, Ito Y, Noda H, Yamashita K.
    Am Heart J; 1986 Feb; 111(2):347-52. PubMed ID: 3511649
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Renal effects of angiotensin-converting enzyme inhibition in cardiac failure.
    Dzau VJ.
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):74-80. PubMed ID: 3037893
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.